The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial (Am J Heart 2005;150:189-92).

Am Heart J

Published: May 2006

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ahj.2005.09.027	DOI Listing

Publication Analysis

vulnerable endothelium

endothelium priming

priming vascular

vascular endothelium

endothelium thrombosis

thrombosis unfractionated

unfractionated heparin

heparin biologic

biologic plausibility

plausibility observations

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!